Back to Search
Start Over
96P Liposomal irinotecan + 5-FU/LV + bevacizumab for second-line treatment of metastatic colorectal cancer (IRIS): A prospective, multi-center, single-arm clinical study.
- Source :
-
Annals of Oncology . 2024 Supplement 4, Vol. 35, pS1440-S1440. 1p. - Publication Year :
- 2024
- Subjects :
- *COLORECTAL cancer
*METASTASIS
*IRINOTECAN
*BEVACIZUMAB
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 35
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 181112338
- Full Text :
- https://doi.org/10.1016/j.annonc.2024.10.118